Introduction
============

The repair of large segmental bone defects caused by trauma or disease is a very difficult process in orthopedic clinics. Sources of autologous bone grafts are limited and allogeneic grafts may be rejected and might induce infection. The effect of artificial bone products for this purpose is still uncertain. Thus, the use of autologous bone marrow stem cells (BMSCs) to build/repair bone tissue and to treat bone defects has been proposed as a new treatment option in recent years. BMSCs are a subset of non-hematopoietic bone marrow stromal cells. They are easy to obtain and culture, and can be amplified *in vitro* and transformed to multi-line ages without loss of genetic stability \[[@B1]\]. BMSCs have a multi-potent differentiation potential *in vitro* under certain conditions. BMSCs can differentiate into adipocytes, osteoblasts, chondrocytes, and vascular smooth muscle, skeletal muscle, heart, endothelial, nerve, and liver cells, among others \[[@B2]\]. Thus, BMSCs have become the most promising seed cells for bone tissue engineering \[[@B3]\].

Bone morphogenetic proteins (BMPs) are bone growth factors that are known to induce osteogenesis \[[@B3]\]. These growth factors themselves are sufficient to induce bone formation \[[@B3]\]. Under certain conditions, they can induce undifferentiated mesenchymal cells to transform to bone cells and promote the proliferation of bone cells \[[@B3]\]. BMPs are currently considered the most important factor in osteogenesis \[[@B4],[@B5]\]. The effect of recombinant human BMP-2 (rhBMP-2) on osteogenic differentiation of BMSCs is well-studied, and rhBMP-2 has already been applied widely in animal experiments and clinical applications \[[@B2]\]. In previous studies, we have also tested the utility of tissue-engineered bone containing rhBMP-2 and BMSCs in repairing bone defects in rabbits \[[@B6],[@B7]\]. However, the molecular mechanisms of BMP-2-induced osteogenic differentiation are currently not known.

The source of BMSC specimens are mainly mice, rats, and humans. Human BMSCs are in limited supply and it is difficult to carry out studies with human BMSCs. BMSCs from mice or rats are quite different from human BMSCs in physiology. Beagle is considered an ideal large animal model widely used in pre-clinical toxicological experiments, basic medical research, radiation sickness treatment, and experimental surgery. Therefore, in this study, we established a model for BMSC primary cell culture and rhBMP-2-induced osteogenic differentiation using Beagle dogs. Proteomic analysis was used to identify proteins regulated by rhBMP-2. The results provide an improved understanding of the rhBMP-2-induced osteogenic differentiation of BMSCs.

Material and methods
====================

Culture and induction of differentiation of BMSCs
-------------------------------------------------

According to standard bone marrow puncture procedures, 5 to 10 mL of bone marrow was aspirated from the posterior superior iliac spine of beagles. Heparin was added to the bone marrows to block coagulation and then the marrows were diluted with an equal volume of phosphate-buffered saline (PBS). The diluted bone marrows were layered onto lymphocyte separation medium (Sigma-Aldrich) at a ratio of 2:1, followed by centrifugation at 400 × *g* for 30 min. After centrifugation, the white layer between the two layers generated after centrifugation was collected and washed twice with PBS. Cells were seeded in culture plates at a density of 1 × 10^6^ cells/well and cultured in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum, 100 U/mL penicillin, and 100 U/mL streptomycin at 37°C in an atmosphere of 5% CO~2~ and 95% humidity. After 72 h of incubation, the culture medium was changed once every 3 days. At the third generation, cells were trypsinized, and 3 × 10^6^ cells were plated in 100 mm culture dishes. The cells were stimulated with 20 mg/L rhBMP-2 (Hangzhou Jiuyuan Gene Engineering Co., Ltd., China) for one week, and the medium was changed once every three days. The morphology of the cells was observed everyday using an inverted phase-contrast microscope (IX81; Olympus, Japan). All protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at Southern Medical University (Approval No. 120333, 114522).

Gomori alkaline phosphatase staining
------------------------------------

Gomori alkaline phosphatase staining was performed on cultured BMSCs as per the instructions of BCIP/NBT chromogenic alkaline phosphatase staining kit (Beyotime, China). After fixation, cells were washed with PBS three times, the BCIP/NBT staining working solution was added, and the cells were incubated at room temperature for 30 min. The BCIP/NBT staining working solution were then removed, and the cells were washed twice with distilled water to terminate the color reaction. The cells were observed and photographed using an inverted phase-contrast microscope (IX81; Olympus, Japan).

Two-dimensional (2D) gel electrophoresis
----------------------------------------

Dry cells (100 mg) were lysed by adding 400 μL of lysis buffer (8 M urea, 4% CHAPS, 0.48% Tris base, 40 mM DTT, and 10 mMphenylmethylsulfonyl fluoride). The lysis mixture was incubated at room temperature for 60 min and centrifuged at 15,000 rpm for 60 min at 4°C. After centrifugation, the supernatant was collected and quantified with a 2D QUANT protein Assay Kit (GE, USA). The supernatant containing 300 μg of total cellular protein (about 20 μL) was mixed with the sample buffer (7 M urea, 2 M thiourea, 4% CHAPS, 65 mM DTT, 0.2% ampholytes, and a small amount of bromophenol blue) to a final volume of 450 μL. Two-dimensional gel electrophoresis (2-DE) was performed mainly according to the method described in a previous report \[[@B8]\] using a 24-cm pH4-7 linear DryStrip (GE, USA). After rehydration, is oelectric focusing (highest current set at 50 μA/gel, 20°C) and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed. After electrophoresis, mass spectrometry-compatible silver staining was applied \[[@B9]\]. The gel was scanned using a UMAX Power Look 1100 transmission scanner to obtain images, and the images were analyzed with PDQuest 7.1.0 software. The analysis included the detection of protein spots, quantification, background removal, and cross-gel analysis. After comparison of the two gels, protein spots corresponding to a difference in expression greater than 2.5 times were selected for matrix-assisted laser desorption/ionization-time-of flight (MALDI-TOF) mass spectrometry.

In-gel digestion and MALDI-TOF mass spectrometry
------------------------------------------------

The protein spots were excised from gels into 1--2 mm^2^ blocks. After in-gel digestion, MALDI-TOF-TOF mass spectrometry was carried out using an ABI4700 (Applied Biosystems, USA) system. The obtained data were analyzed with the PMF Mascot database (<http://www.matrixscience.com/>). The parameters used were: species, mammal; trypsin digestion (the number of maximum missed cleavages was set to 1); carbamidomethylation of cysteine residues was set as a fixed modification; and mass error, 100 ppm.

Real-time quantitative PCR
--------------------------

The RNA extracted from BMSCs (1 μg) was first reverse-transcribed into cDNA (PrimeScript; Takara, China). The cDNA was then used as the template for real-time quantitative PCR analysis (Maxima SYBR Green/ROX qPCR Master Mix; Thermo Scientific, Pittsburgh, PA). The primers for quantifying the mRNA expression of Lim and SH3 domain protein 1 (LASP1), ferritin light and heavy chains, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), which served as the internal control, are listed below (Table [1](#T1){ref-type="table"}). The average ΔΔCT of LASP1, ferritin light and heavy chains, and GAPDH from samples analyzed in triplicate was calculated \[[@B10],[@B11]\].

###### 

Sequences of primers used in real-time quantitative PCR

  **Gene**                         **Gen bank accession no.**   **Primers**
  -------------------------------- ---------------------------- --------------------------------
  GAPDH                            NM_001003142.1               F: 5ʹ-ATCATCAGCAATGCCTCCTG-3ʹ
  R: 5ʹ-ATGGACTGTGGTCATGAGTC-3ʹ                                 
  LASP1                            XM_859075.2                  F: 5ʹ- GTGCGCTACAAGGAGGAGTT-3ʹ
  R: 5ʹ- CTCTGGAGTTCGGGTGTGTC-3ʹ                                
  Ferritin light chain             NM_001024636.1               F: 5ʹ-AGGCCCTTTTGGATCTTCAT-3ʹ
  R: 5ʹ-CAGGTGGTCACCCATCTTCT-3ʹ                                 
  Ferritin heavy chain             NM_001003080.1               F: 5ʹ-CTGGAGCTCTACGCCTCCTA-3ʹ
  R: 5ʹ-TGGTTCTGCAGCTTCATCAG-3ʹ                                 

Western blotting
----------------

BMSCs in the exponential growth phase were lysed with radio-immunoprecipitation assay (RIPA) buffer. The expression level of LASP1 and ferritin light and heavy chains in BMSC lysates were analyzed by western blotting. The protein concentration of cell lysates was examined before resolving the total cellular protein (50 μg/lane) using SDS-PAGE. The proteins were transferred onto nitrocellulose membranes and the membranes were then blocked using 5% skim non-fat milk in Tris-buffered saline (TBS). The membranes were then incubated with primary antibodies specific for LASP1 (ab117806; Abcam, USA), ferritin light chain (ab69090; Abcam, USA), and ferritin heavy chain (ab65080; Abcam, USA). The membranes were washed three times in TBS containing 0.1% Tween 20 and then incubated with the appropriate secondary antibodies. The protein-antibody complexes were detected using a chemiluminescence reagent kit (ECL; Pierce Bio, USA). The protein-specific bands were analyzed by semi-quantitative densitometry.

Statistical analysis
--------------------

The data obtained from real-time quantitative PCR and the density of protein bands from western blotting analysis were analyzed with SPSS12.0 software (SPSS Inc., Chicago, IL). The data shown are the mean ± SD. The comparison of quantitative data was carried out using independent sample *t*-test and a value of *p* \< 0.05 was considered to be statistically significant.

Results
=======

rhBMP-induced osteogenesis in BMSCs
-----------------------------------

The BMSCs were cultured and treated with rhBMP-2 as described in materials and methods. The cell morphology was analyzed by observation under a microscope. The non-induced cells were short, with spindle-like fusiform shapes. At day 7 of culture, the number of cells increased, the size of the cells enlarged, and the cells became elongated (Figure [1](#F1){ref-type="fig"}A, control). During continued culture, the cells remained long and spindle-shaped. After induction with rhBMP-2, the shapes of the BMSCs began changing gradually. Seven days after induction, the cell morphology drastically changed from long spindle-like cells to cubic cells (Figure [1](#F1){ref-type="fig"}A, BMP-2). The osteogenesis potential of rhBMP-2-induced BMSCs was evaluated by staining for alkaline phosphatase activity, a marker for ostoeblastic differentiation. When BMSCs were treated with rhBMP-2 for 7 days, a lot of dark blue dots appeared, indicating the presence of alkaline phosphatase activity (Figure [1](#F1){ref-type="fig"}B, BMP-2). In BMSCs that had not been treated with rhBMP-2, only a few alkaline phosphatase spots were detected (Figure [1](#F1){ref-type="fig"}B, control). These results show that BMSCs from beagles can be successfully cultured and that osteogenes can be induced by treatment with rhBMP-2.

![**rhBMP-2-induced BMSC osteogenic differentiation. (A)** Cell morphology of BMSCs without or with rhBMP-2 induction (labeled as control and BMP-2, respectively). The magnification is 100X. **(B)** Alkaline phosphatase staining was used to determine the status of osteogenic differentiation of BMSCs, without or with treatment with rhBMP-2. The image magnification is 100X.](1477-5956-12-13-1){#F1}

Two-dimensional gel electrophoresis
-----------------------------------

The protein extracts from non-induced and rhBMP-2 induced BMSCs were examined by two-dimensional gel electrophoresis followed by silver staining. The images of the silver-stained gels were clear and without background interference (Figure [2](#F2){ref-type="fig"}A, control and BMP-2). The protein spots were completely separated and similar results were obtained in all three independent trials of the experiment. An average of 1125 protein spots could be identified in the gel images from the three independent trials. The matching protein spots in the gels corresponding to the control (non-induced) and rhBMP-2-treated samples were considered to originate from the same proteins. The results showed that the percentage of matched proteins from the two groups of cells was approximately 90.84%.

![**Proteomics analysis of protein expression profiles in rhBMP-2-induced BMSCs. (A)** 2D gel electrophoresis maps of BMSCs without or with rhBMP-2 induction (labeled as control and BMP-2, respectively). **(B and C)** Close-up images of cropped sections of 2-DE maps shown in **(A)**. Protein number 4, LASP1; Number 11 and 12, ferritin light and heavy chains.](1477-5956-12-13-2){#F2}

After manual comparison and PDQuest 7.1.0 software analysis of the protein spots, 20 proteins with significant differences of expression levels between the control and induced cells were selected for further analysis. The differences were categorized as proteins that were up-or down-regulated by 2 times or more, and proteins that were either down-regulated (9 proteins) or up-regulated (11 proteins) in the BMP-2-induced cells were analyzed further by MALDI-TOF mass spectrometry for protein identification (Table [2](#T2){ref-type="table"}). The proteins numbered as 4, 11, and 12 in Table [2](#T2){ref-type="table"} were identified as LASP1 isoform 2, ferritin light chain, and ferritin heavy chain (Figure [2](#F2){ref-type="fig"}B and C, marked by red arrows). Mass spectrometry peptide fingerprint peaks of these three proteins are shown in Figure [3](#F3){ref-type="fig"}A-C, respectively. The expression of the mRNAs corresponding to these three proteins in control and BMP-2-treated cells was examined by real-time quantitative PCR. Compared with the expression levels in the control cells, the expression of LASP1 decreased, while that of ferritin light and heavy chains increased, in the rhBMP-2-induced cells (*p* \< 0.05) (Figure [4](#F4){ref-type="fig"}A). The expression levels of these three proteins in the non-induced and induced cells were also examined by western blotting. Consistent with the expression data for the mRNA, LASP1 protein levels were higher in control cells, while the levels of ferritin light and heavy chains was higher in the BMP-2-treated cells (Figure [4](#F4){ref-type="fig"}B). Densitometric analysis of protein bands from the western blots also indicated the same pattern of expression as that from the real-time quantitative PCR analysis of mRNA expression (*p* \< 0.05) (Figure [4](#F4){ref-type="fig"}B).

###### 

The proteins identified by proteomics analysis

                             **Name**                                                                        **Accession number**   **Protein score**   **Mass**   **pI**   **Peptides identified**   **% Peptide coverage**   **rhBMP-2 induction/Control**
  -------------------------- ------------------------------------------------------------------------------- ---------------------- ------------------- ---------- -------- ------------------------- ------------------------ -------------------------------
  1                          Eukaryotic translation initiation factor 3 subunit K isoform 1                  gi\|57036583           95                  25342.6    4.81     YNPENLATLER               25.7                     0.3
  ALTNLPHTDFTLCK                                                                                                                                                                                                               
  GIDRYNPENLATLER                                                                                                                                                                                                              
  CMIDQAHQEERPIR                                                                                                                                                                                                               
  2                          Heat shock protein beta-6                                                       gi\|57038366           100                 17382.1    5.95     HFSPEEIAVK                21                       \<0.1
  VVGDHVEVHAR                                                                                                                                                                                                                  
  HEERPDEHGYIAR                                                                                                                                                                                                                
  3                          Annexin A8 isoform 1                                                            gi\|73953207           102                 36827.5    5.53     VFEEYER                   39                       \<0.1
  FITILCTR                                                                                                                                                                                                                     
  NLHSYFAER                                                                                                                                                                                                                    
  ILVCLLQGSR                                                                                                                                                                                                                   
  EGVIIEILASR                                                                                                                                                                                                                  
  GIGTNEQAIIDVLTR                                                                                                                                                                                                              
  DLTETLQSELSGKFER                                                                                                                                                                                                             
  NLHSYFAERLYYALK                                                                                                                                                                                                              
  GSPHFNPEPDAEALYTAMK                                                                                                                                                                                                          
  AQFGKDLTETLQSELSGK                                                                                                                                                                                                           
  4                          LIM and SH3 domain protein 1 isoform 2                                          gi\|73966152           89                  30162.4    6.33     EPAAPVSIPR                38                       \<0.1
  QQSELQSQVR                                                                                                                                                                                                                   
  IPYCNAHYPK                                                                                                                                                                                                                   
  GFSVVADTPELQR                                                                                                                                                                                                                
  LKQQSELQSQVR                                                                                                                                                                                                                 
  GKGFSVVADTPELQR                                                                                                                                                                                                              
  QSFTMVADTPENLR                                                                                                                                                                                                               
  TQDQISNIKYHEEFEK                                                                                                                                                                                                             
  5                          Glucose-6-phosphate isomerase                                                   gi\|296080693          94                  63147      8.42     VDHQTGPIVWG               7.5                      \<0.1
  KTFTTQETIT                                                                                                                                                                                                                   
  RSGDWKGYTGCETHAMLP YDQ                                                                                                                                                                                                       
  6                          RAD23 homolog B                                                                 gi\|57094213           99                  43171      4.77     A PTPVPALAPT              10.6                     \<0.1
  QAYFACEKNEN                                                                                                                                                                                                                  
  AAKQEKPAEK                                                                                                                                                                                                                   
  VVMVTKPKAVS                                                                                                                                                                                                                  
  7                          Fibronectin 1                                                                   gi\|345797318          99                  262625     5.46     LEPGTEYTI                 3                        \<0.1
  RARIAGYRLT                                                                                                                                                                                                                   
  CSTTSNYEQDQ                                                                                                                                                                                                                  
  STSQTTAPDAP                                                                                                                                                                                                                  
  YVVGETWEKPYQG                                                                                                                                                                                                                
  LSISPSDNVVVLTNLL                                                                                                                                                                                                             
  8                          Poly(rC) binding protein 1                                                      gi\|222352151          95                  37498      6.66     SSSPEVKGYWA               7                        \<0.1
  NSSMTNSTAASRPP                                                                                                                                                                                                               
  9                          Signal transducer and activator of transcription 1                              gi\|74005006           68                  87335      5.74     FHAVEPYTK                 6                        \<0.1
  LWYNMLVTE                                                                                                                                                                                                                    
  RQQSACIGGPPN                                                                                                                                                                                                                 
  VIDLETTSLPVVV                                                                                                                                                                                                                
  10                         Retinol-binding protein 4                                                       gi\|73998292           100                 30177      8.48     QEELCLAR                  49                       \>10
  RLPSVFHPGR                                                                                                                                                                                                                   
  DPNGLPLEAQK                                                                                                                                                                                                                  
  QRQEELCLAR                                                                                                                                                                                                                   
  LIVHNGYCDGR                                                                                                                                                                                                                  
  LIVHNGYCDGRSEPNTL                                                                                                                                                                                                            
  LLNLDGTCADSYSFVFSR                                                                                                                                                                                                           
  KDPEGLFLQDNIVAEFSVDENGR                                                                                                                                                                                                      
  GNDDHWIIDTDYDTYAVQYSCR                                                                                                                                                                                                       
  11                         Ferritin light chain                                                            gi\|66864897           100                 20139.2    5.66     MGDHLTNLRR                73                       4
  ELAEEKREGAER                                                                                                                                                                                                                 
  DDVALEGVGHFFR                                                                                                                                                                                                                
  QNYSTEVEAAVNR                                                                                                                                                                                                                
  LATPQAGLGEYLFER                                                                                                                                                                                                              
  SLNQALLDLHALGSAR                                                                                                                                                                                                             
  ASYTYLSLGFYFDR                                                                                                                                                                                                               
  RLATPQAGLGEYLFER                                                                                                                                                                                                             
  ADPHLCDFLENHFLDEEVK                                                                                                                                                                                                          
  12                         Ferritin heavy chain                                                            gi\|302393573          100                 21408.4    5.53     ELGDHVTNLR                66                       3
  SVNQSLLELHK                                                                                                                                                                                                                  
  YFLHQSHEER                                                                                                                                                                                                                   
  IFLQDIKKPDR                                                                                                                                                                                                                  
  SIKELGDHVTNLR                                                                                                                                                                                                                
  QNYHQDSEAAINR                                                                                                                                                                                                                
  SIKELGDHVTNLRK                                                                                                                                                                                                               
  YFLHQSHEEREHAEK                                                                                                                                                                                                              
  LATDKNDPHLCDFIETHYLNEQVK                                                                                                                                                                                                     
  13                         Annexin A4                                                                      gi\|55742853           96                  36075.2    5.72     VLVSLSAGGR                60                       \>10
  FLTVLCSR                                                                                                                                                                                                                     
  NKSAYFAER                                                                                                                                                                                                                    
  SDTSFMFQR                                                                                                                                                                                                                    
  DEGNFLDDALMR                                                                                                                                                                                                                 
  NHLLHVFDEYKR                                                                                                                                                                                                                 
  NRNHLLHVFDEYK                                                                                                                                                                                                                
  SLYSFIKGDTSGDYR                                                                                                                                                                                                              
  AEIDMMDIRESFKR                                                                                                                                                                                                               
  SLYSFIKGDTSGDYRK                                                                                                                                                                                                             
  NRNHLLHVFDEYKR                                                                                                                                                                                                               
  DLMDDLKSELSGNFER                                                                                                                                                                                                             
  GGTVKPASGFSATEDAQTLR                                                                                                                                                                                                         
  VLVSLSAGGRDEGNFLDDALMR                                                                                                                                                                                                       
  14                         Proteasome activator complex subunit 3, isoform 6                               gi\|73965646           84                  29601.6    5.69     YPHVEDYR                  45                       3
  LKVDSFRER                                                                                                                                                                                                                    
  YPHVEDYRR                                                                                                                                                                                                                    
  IAKYPHVEDYRR                                                                                                                                                                                                                 
  RLDECEEAFQGTK                                                                                                                                                                                                                
  TVESEAASYLDQISR                                                                                                                                                                                                              
  ITSEAEDLVANFFPK                                                                                                                                                                                                              
  TVTEIDEKEYISLR                                                                                                                                                                                                               
  IEDGNNFGVSIQEETVAELR                                                                                                                                                                                                         
  15                         Adenosylhomocysteinase isoform 1                                                gi\|73991635           100                 48260.4    5.98     RIILLAEGR                 14.8                     3
  FDNLYGCR                                                                                                                                                                                                                     
  YPQLLSGIR                                                                                                                                                                                                                    
  VNIKPQVDR                                                                                                                                                                                                                    
  SKFDNLYGCR                                                                                                                                                                                                                   
  VAVVAGYGDVGKGCAQALR                                                                                                                                                                                                          
  16                         Histidyl-tRNA synthetase, cytoplasmic, isoform 1                                gi\|73949318           73                  57880.3    5.44     IFSIVEQR                  8                        \>10
  YDLTVPFAR                                                                                                                                                                                                                    
  DQGGELLSLR                                                                                                                                                                                                                   
  KVPCVGLSIGVER                                                                                                                                                                                                                
  17                         Solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3   gi\|119618005          87                  40,095     9.45     SVVSVLNKE                 10                       4
  DAAPKMYKEEGL                                                                                                                                                                                                                 
  IFNGFSVTLKEDGVRG                                                                                                                                                                                                             
  18                         ATP-binding cassette, sub-family B (MDR/TAP), member 1                          gi\| 51094928          101                 141479     9.06     EGLMPNTL                  6                        3
  LSLEVKKG                                                                                                                                                                                                                     
  AVKEANAYDFI                                                                                                                                                                                                                  
  GLQPAFAIIFSKIIG                                                                                                                                                                                                              
  LTLVILAISPVLGLS                                                                                                                                                                                                              
  AGNLEDLMSNITNRSDIND                                                                                                                                                                                                          
  19                         DEAD (Asp-Glu-Ala-Asp) box helicase 1                                           gi\| 148666036         66                  82432      6.80     ERLGKNHI                  7                        \>4
  CLHGDRKPHERKQN                                                                                                                                                                                                               
  GCYLDIDKGHVKFSK                                                                                                                                                                                                              
  AIGSDGLCCQSREVKE                                                                                                                                                                                                             
  20                         Isocitrate dehydrogenase 1 (NADP+), soluble                                     gi\|119590847          99                  46659      6.53     EVSIETIEA                 11                       3
  SPNGTIRNI                                                                                                                                                                                                                    
  GTQKVTYLVHNF                                                                                                                                                                                                                 
  DDMVAQAMKSEGGFI                                                                                                                                                                                                              
  21                         Filamin B, beta                                                                 gi\| 410336835         73                  278164     5.47     LEFLDRES                  2.5                      3
  EAGEGDVSV                                                                                                                                                                                                                    
  PHVVKVFFAG                                                                                                                                                                                                                   
  ECSDNGDGTCS                                                                                                                                                                                                                  
  ILVKYNDKHIPGS                                                                                                                                                                                                                
  KQPAKFTVDTISAG                                                                                                                                                                                                               

![**Peptide fingerprint map obtained using MALDI-TOF mass spectrometry. (A)** LASP1. **(B)** Ferritin light chain. **(C)** Ferritin heavy chain.](1477-5956-12-13-3){#F3}

![**Confirmation of RNA and protein expression levels by real-time quantitative PCR and western blotting analysis (n = 3, per treatment type). (A)** The expression of LASP1 and ferritin light and heavy chain mRNAs relative to that of GAPDH, the internal control, as detected by real-time PCR. **(B)** Expression of LASP1 and ferritin light and heavy chains, as assessed by western blotting analysis. The signal corresponding to the protein bands was quantified using densitometric scanning and the relative protein abundance was determined after normalization with the levels of β-actin protein. Data are presented as mean ± SD and compared using the *t*-test for independent samples. \**p* \<0.05, indicating significant differences between the two samples compared.](1477-5956-12-13-4){#F4}

Discussion
==========

In this study, beagle BMSCs were successfully isolated and cultured. The BMSCs were stimulated with rhBMP-2 to induce osteogenic differentiation. After 7 days of stimulation, osteogenic differentiation of BMSCs was seen, confirmed by the morphological changes in BMSCs and the appearance of alkaline phosphatase activity, a marker for osteoblastic differentiation. The protein expression profiles of untreated control and rhBMP-2-treated BMSCs were characterized using 2D gel electrophoresis. Comparison of the two protein expression profiles indicated that 9 proteins were up-regulated and 11 proteins were down-regulated after stimulation of BMSCs with rhBMP-2. Based on previously published reports and bioinformatics analysis, two proteins, LASP1 and ferritin (light and heavy chains), were selected for further analysis as candidate proteins involved in osteogenic differentiation induced by BMP-2. The results from real-time quantitative PCR and western blotting analyses confirmed the down-regulation of LASP1 and the up-regulation of ferritin in rhBMP-2-induced BMSCs.

LASP1 protein contains one LIM, one SH3, and two actin domains, and was first discovered in 1996 as a protein that is over-expressed in breast cancer \[[@B12]\]. Studies about LASP1 have almost all concentrated on LASP1 expression in tumors. LASP1 is involved in regulating cellular functions associated with actin-cytoskeleton-associated membrane rearrangements \[[@B13]-[@B15]\]. One study showed that aberrant expression of LASP1 can affect the formation of cartilage tissue \[[@B16]\]. To our knowledge, ours is the first study demonstrating a decrease in LASP1 expression during the process of rhBMP-2-induced osteogenic differentiation.

Ferritin is an important molecule in iron homeostasis in cells \[[@B17]\]. Iron overload can inhibit osteoblast differentiation and induce ferritin expression. Iron-provoked inhibition of osteoblast activity is mediated by ferritin and its ferroxidase activity \[[@B18]\]. We found that the expression of ferritin light and heavy chains was increased in BMSCs after induction of differentiation by rhBMP-2. The possible role for the up-regulation of ferritin might be that when stem cells in bone marrow are stimulated by rhBMP-2, over-expression of ferritin causes the enrichment of iron, thereby inhibiting osteogenic differentiation. However, the concentration of iron ions in the culture medium is maintained at steady levels, hence osteogenic differentiation is not inhibited under *in vitro* culture conditions, even though ferritin expressed is increased upon stimulation with rhBMP-2. The extent and exact mechanism(s) through which the expression of LASP1 and ferritin are altered upon stimulation with BMP-2 need to be addressed in further mechanistic studies of osteogenic differentiation of BMSCs.

In summary, rhBMP-2 induces osteogenic differentiation of BMSCs, decreases LASP1 expression, and increases ferritin expression. LASP1 is a key factor involved in the regulation of the cytoskeleton and ferritin controls cellular iron homeostasis, and the expression changes in these proteins likely play an important role in the process of rhBMP-2-induced osteogenic differentiation. The results of this study provide additional information regarding the role of changes in expression of specific proteins in driving BMP-2-induced osteogenic differentiation and indicate the need for further studies to elucidate the specific mechanism(s) through which BMP-2 promotes differentiation of BMSCs.
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